Announcement on Voluntary Disclosure on Acceptance of Marketing Application for Tallecimab Injection for Adult Seasonal Allergic Rhinitis

About this update from Chongqing Genrix Biopharmaceutical Co., Ltd. Class A

Announcement on Voluntary Disclosure on Acceptance of Marketing Application for Tallecimab Injection for Adult Seasonal Allergic Rhinitis The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Chongqing Genrix Biopharmaceutical Co., Ltd. Class A